Results show consistent improvements in wakefulness, cataplexy, and quality of life with oveporexton for patients with narcolepsy.
|Articles|May 7, 2007
WorkingRX and Jopari team up for paperless processing
Workers' compensation claims processor WorkingRx and Jopari Solutions, a developer of electronic billing systems, have implemented an end-to-end system for the electronic processing of pharmacy workers? compensations bills.
Advertisement
Workers' compensation claims processor WorkingRx and Jopari Solutions, a developer of electronic billing systems, have implemented an end-to-end system for the electronic processing of pharmacy workers' compensations bills. The two firms are already beginning to transition customers to paperless processing. Pharmacy payments as a percentage of all workers' comp medical losses are rapidly growing, with pharmaceutical benefits currently exceeding 8% of medical losses, by some estimates. The new system captures the data from the point of sale, processes the claim, and even carries out state medical reporting compliance services.
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.
Practical takeaways to improve real‑world clinic outcomes for PAINWeek 2026.
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
The trial found that up to 25 days of nirmatrelvir-ritonavir did not improve cognitive, autonomic, or exercise-related symptoms compared with placebo.
Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.
ACIP changes, new court rulings, and coverage gaps threaten vaccines, pharmacists’ reimbursement, and children's access through Vaccine For Children.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Nirmatrelvir-Ritonavir Shows No Benefit for Long COVID
3
Expert Discusses Flu and COVID-19 Vaccine Guidance
4
Generic Drug Costs Burdening Patients as Much as Brand Name Options
5